210 related articles for article (PubMed ID: 8429445)
1. Improved pulmonary outcome after exogenous surfactant therapy for respiratory failure in term infants requiring extracorporeal membrane oxygenation.
Lotze A; Knight GR; Martin GR; Bulas DI; Hull WM; O'Donnell RM; Whitsett JA; Short BL
J Pediatr; 1993 Feb; 122(2):261-8. PubMed ID: 8429445
[TBL] [Abstract][Full Text] [Related]
2. Phospholipid and surfactant protein A concentrations in tracheal aspirates from infants requiring extracorporeal membrane oxygenation.
Bui KC; Walther FJ; David-Cu R; Garg M; Warburton D
J Pediatr; 1992 Aug; 121(2):271-4. PubMed ID: 1640296
[TBL] [Abstract][Full Text] [Related]
3. Surfactant (beractant) therapy for infants with congenital diaphragmatic hernia on ECMO: evidence of persistent surfactant deficiency.
Lotze A; Knight GR; Anderson KD; Hull WM; Whitsett JA; O'Donnell RM; Martin G; Bulas DI; Short BL
J Pediatr Surg; 1994 Mar; 29(3):407-12. PubMed ID: 8201510
[TBL] [Abstract][Full Text] [Related]
4. Multicenter study of surfactant (beractant) use in the treatment of term infants with severe respiratory failure. Survanta in Term Infants Study Group.
Lotze A; Mitchell BR; Bulas DI; Zola EM; Shalwitz RA; Gunkel JH
J Pediatr; 1998 Jan; 132(1):40-7. PubMed ID: 9469998
[TBL] [Abstract][Full Text] [Related]
5. Surfactant application during extracorporeal membrane oxygenation improves lung volume and pulmonary mechanics in children with respiratory failure.
Hermon M; Burda G; Male C; Boigner H; Ponhold W; Khoss A; Strohmaier W; Trittenwein G
Crit Care; 2005; 9(6):R718-24. PubMed ID: 16280067
[TBL] [Abstract][Full Text] [Related]
6. Surfactant protein A concentrations in tracheal aspirate fluid from infants requiring extracorporeal membrane oxygenation.
Lotze A; Whitsett JA; Kammerman LA; Ritter M; Taylor GA; Short BL
J Pediatr; 1990 Mar; 116(3):435-40. PubMed ID: 2308037
[TBL] [Abstract][Full Text] [Related]
7. Surfactant replacement therapy for meconium aspiration syndrome.
Findlay RD; Taeusch HW; Walther FJ
Pediatrics; 1996 Jan; 97(1):48-52. PubMed ID: 8545223
[TBL] [Abstract][Full Text] [Related]
8. Survivors of extracorporeal membrane oxygenation at 1 year of age: the relationship of primary diagnosis with health and neurodevelopmental sequelae.
Bernbaum J; Schwartz IP; Gerdes M; D'Agostino JA; Coburn CE; Polin RA
Pediatrics; 1995 Nov; 96(5 Pt 1):907-13. PubMed ID: 7478834
[TBL] [Abstract][Full Text] [Related]
9. Surfactant therapy in full-term neonates with severe respiratory failure.
Khammash H; Perlman M; Wojtulewicz J; Dunn M
Pediatrics; 1993 Jul; 92(1):135-9. PubMed ID: 8516059
[TBL] [Abstract][Full Text] [Related]
10. Use of surfactant in pulmonary disorders in full-term infants.
Sun B
Curr Opin Pediatr; 1996 Apr; 8(2):113-7. PubMed ID: 8723804
[TBL] [Abstract][Full Text] [Related]
11. Extracorporeal membrane oxygenation in infants with meconium aspiration syndrome: a decade of experience with venovenous ECMO.
Kugelman A; Gangitano E; Taschuk R; Garza R; Riskin A; McEvoy C; Durand M
J Pediatr Surg; 2005 Jul; 40(7):1082-9. PubMed ID: 16034749
[TBL] [Abstract][Full Text] [Related]
12. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
Stevens TP; Blennow M; Soll RF
Cochrane Database Syst Rev; 2004; (3):CD003063. PubMed ID: 15266470
[TBL] [Abstract][Full Text] [Related]
13. A pilot, randomized, controlled clinical trial of lucinactant, a peptide-containing synthetic surfactant, in infants with acute hypoxemic respiratory failure.
Thomas NJ; Guardia CG; Moya FR; Cheifetz IM; Markovitz B; Cruces P; Barton P; Segal R; Simmons P; Randolph AG;
Pediatr Crit Care Med; 2012 Nov; 13(6):646-53. PubMed ID: 22791092
[TBL] [Abstract][Full Text] [Related]
14. Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure.
Neonatal Inhaled Nitric Oxide Study Group
N Engl J Med; 1997 Feb; 336(9):597-604. PubMed ID: 9036320
[TBL] [Abstract][Full Text] [Related]
15. Treatment of severe non-neonatal ARDS in children with surfactant and nitric oxide in a "pre-ECMO"-situation.
Möller JC; Schaible TF; Reiss I; Artlich A; Gortner L
Int J Artif Organs; 1995 Oct; 18(10):598-602. PubMed ID: 8647590
[TBL] [Abstract][Full Text] [Related]
16. Surfactant Administration During Pediatric Cardiac Extracorporeal Membrane Oxygenation.
Chrysostomou C; Maul T; Istvanic F; Wearden P
ASAIO J; 2019; 65(4):367-370. PubMed ID: 29762231
[TBL] [Abstract][Full Text] [Related]
17. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for RDS.
Stevens TP; Blennow M; Soll RF
Cochrane Database Syst Rev; 2002; (2):CD003063. PubMed ID: 12076469
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary sequelae at six months following extracorporeal membrane oxygenation.
Garg M; Kurzner SI; Bautista DB; Lew CD; Ramos AD; Platzker AC; Keens TG
Chest; 1992 Apr; 101(4):1086-90. PubMed ID: 1555425
[TBL] [Abstract][Full Text] [Related]
19. Effects of exogenous surfactant therapy on dynamic compliance during mechanical breathing in preterm infants with hyaline membrane disease.
Couser RJ; Ferrara TB; Ebert J; Hoekstra RE; Fangman JJ
J Pediatr; 1990 Jan; 116(1):119-24. PubMed ID: 2404097
[TBL] [Abstract][Full Text] [Related]
20. Decreased use of neonatal extracorporeal membrane oxygenation (ECMO): how new treatment modalities have affected ECMO utilization.
Hintz SR; Suttner DM; Sheehan AM; Rhine WD; Van Meurs KP
Pediatrics; 2000 Dec; 106(6):1339-43. PubMed ID: 11099586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
